57. Transl Oncol. 2018 Jul 11;11(5):1090-1096. doi: 10.1016/j.tranon.2018.06.006.[Epub ahead of print]Importance of RIP140 and LCoR Sub-Cellular Localization for Their AssociationWith Breast Cancer Aggressiveness and Patient Survival.Sixou S(1), Müller K(2), Jalaguier S(3), Kuhn C(4), Harbeck N(5), Mayr D(6),Engel J(7), Jeschke U(8), Ditsch N(9), Cavaillès V(10).Author information: (1)Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt,Klinikum der Ludwig-Maximilians-Universität, Maistrasse 11, D-80337 München,Germany; Université Paul Sabatier Toulouse III, Faculté des SciencesPharmaceutiques, F-31062 Toulouse cedex 09, France. Electronic address:sophie.doisneausixou@med.lmu.de.(2)Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt,Klinikum der Ludwig-Maximilians-Universität, Maistrasse 11, D-80337 München,Germany. Electronic address: kontakt@katharinamueller.net.(3)IRCM - Institut de Recherche en Cancérologie de Montpellier, INSERM U1194,Université Montpellier, Parc Euromédecine, 208 rue des Apothicaires, F-34298Montpellier Cedex 5, France. Electronic address: stephan.jalaguier@inserm.fr.(4)Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt,Klinikum der Ludwig-Maximilians-Universität, Maistrasse 11, D-80337 München,Germany. Electronic address: christina.kuhn@med.uni-muenchen.de.(5)Brustzentrum der Universität München, Klinik und Poliklinik fürFrauenheilkunde und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität,Maistrasse 11, D-80337 München, Germany. Electronic address:nadia.harbeck@med.uni-muenchen.de.(6)Department of Pathology, Campus Innenstadt, Ludwig-Maximilians-UniversityHospital, Thalkirchner Str. 36, D-80337 Munich, Germany. Electronic address:doris.mayr@med.uni-muenchen.de.(7)Tumorregister München (TRM) des Tumorzentrums München (TZM) am Klinikum derUniversität München (KUM), Marchionistraße 15, 81377 Munich, Germany. Electronic address: engel@ibe.uni-muenchen.de.(8)Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt,Klinikum der Ludwig-Maximilians-Universität, Maistrasse 11, D-80337 München,Germany. Electronic address: Udo.Jeschke@med.uni-muenchen.de.(9)Department of Obstetrics and Gynaecology, Campus Großhadern,Ludwig-Maximilians-University Hospital, Marchionistraße 15, 81377 Munich,Germany. Electronic address: nina.ditsch@med.uni-muenchen.de.(10)IRCM - Institut de Recherche en Cancérologie de Montpellier, INSERM U1194,Université Montpellier, Parc Euromédecine, 208 rue des Apothicaires, F-34298Montpellier Cedex 5, France. Electronic address: vincent.cavailles@inserm.fr.New markers are needed to improve diagnosis and to personalize treatments forpatients with breast cancer (BC). Receptor-interacting protein of 140 kDa(RIP140) and ligand-dependent corepressor (LCoR), two transcriptionalco-regulators of estrogen receptors, strongly interact in BC cells. Althoughtheir role in cancer progression has been outlined in the last few years, theirfunction in BC has not been elucidated yet. In this study, we investigated RIP140and LCoR localization (cytoplasm vs nucleus) in BC samples from awell-characterized cohort of patients (n = 320). RIP140 and LCoR were expressedin more than 80% of tumors, (predominantly in the cytoplasm), and the two markerswere highly correlated. Expression of RIP140 and LCoR in the nucleus wasnegatively correlated with tumor size. Conversely, RIP140 and LCoR cytoplasmicexpression strongly correlated with expression of two tumor aggressivenessmarkers: N-cadherin and CD133 (epithelial mesenchymal transition and cancer stem cell markers, respectively). Finally, high RIP140 nuclear expression wassignificantly correlated with longer overall survival, whereas high total orcytoplasmic expression of RIP140 was associated with shorter disease-freesurvival. Our study strongly suggests that the role of RIP140 and LCoR in BCprogression could vary according to their prevalent sub-cellular localization,with opposite prognostic values for nuclear and cytoplasmic expression. Theinvolvement in BC progression/invasiveness of cytoplasmic RIP140 could bebalanced by the anti-tumor action of nuclear RIP140, thus explaining the previouscontradictory findings about its role in BC.Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.DOI: 10.1016/j.tranon.2018.06.006 PMCID: PMC6070698PMID: 30007204 